ALLO logo
ALLO

Allogene Therapeutics Inc

Biotechnology

Allogene Therapeutics Inc (ALLO) Earnings

Last reported
May 13, 2026
EPS estimate
-$0.19
EPS actual
Revenue est.
$2.0K
Revenue actual